13F History

Aristotle Atlantic Partners, LLC

Holdings History for Sage Therapeutics, Inc. - COM (SAGE)

Symbol: SAGE on Nasdaq
Investment type: Equity - Shares of Stock
Class: COM

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
9/30/2023		-0.35%	$0	0	-197,626	-100%		Q3 2023
6/30/2023	0.35%	+0.07%	$9.29M	198K	+41,107	+26.3%	$47.02	Q2 2023
3/31/2023	0.34%	+0%	$6.57M	157K	+422	+0.27%	$41.96	Q1 2023
12/31/2022	0.33%	0%	$5.95M	156K	-381	-0.24%	$38.14	Q4 2022
9/30/2022	0.37%	+0%	$6.13M	156K	+1,360	+0.88%	$39.16	Q3 2022
6/30/2022	0.39%	+0.01%	$5.01M	155K	+3,015	+1.98%	$32.30	Q2 2022
3/31/2022	0.31%	+0%	$5.04M	152K	+1,206	+0.8%	$33.10	Q1 2022
12/31/2021	0.37%	-0.03%	$6.42M	151K	-10,393	-6.44%	$42.55	Q4 2021
9/30/2021	0.47%	+0%	$7.15M	161K	+85	+0.05%	$44.31	Q3 2021
6/30/2021	0.6%	+0%	$9.16M	161K	+144	+0.09%	$56.81	Q2 2021
3/31/2021	0.88%	+0%	$12.1M	161K	+256	+0.16%	$74.85	Q1 2021
12/31/2020	1.07%	+0.02%	$13.9M	161K	+3,535	+2.25%	$86.51	Q4 2020
9/30/2020	0.85%	+0.47%	$9.61M	157K	+86,887	+123%	$61.12	Q3 2020
6/30/2020	0.28%	+0.06%	$2.93M	70.4K	+15,559	+28.4%	$41.59	Q2 2020
3/31/2020	0.24%	-0.06%	$1.57M	54.8K	-12,789	-18.9%	$28.71	Q1 2020
12/31/2019	0.62%	+0.49%	$4.88M	67.6K	+53,603	+383%	$72.19	Q4 2019
9/30/2019	0.57%	+0%	$1.97M	14K	+107	+0.77%	$140.33	Q3 2019
6/30/2019	0.74%	0%	$2.55M	13.9K	-46	-0.33%	$183.05	Q2 2019
3/31/2019	0.67%	+0.1%	$2.22M	13.9K	+2,033	+17.1%	$159.08	Q1 2019
12/31/2018	0.4%		$1.14M	11.9K			$95.75	Q4 2018
9/30/2018			$961K	8.7K			$110.46^*	Q3 2018
6/30/2018	0.47%	+0.47%	$1.36M	8.7K	+8,700	NEW	$156.32	Q2 2018

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.